Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res. 1989 Nov-Dec; 4(3):222-9.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Anticonvulsants
Dose-Response Relationship, Drug
Double-Blind Method
Drug Combinations
Epilepsy, Temporal Lobe
Female
Humans
Male
Middle Aged
Triazines